• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心房颤动早期发生之前和期间,拉伸引起的心房结构变化的机制。

Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.

机构信息

Department of Experimental Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands.

出版信息

Cardiovasc Res. 2011 Mar 1;89(4):754-65. doi: 10.1093/cvr/cvq357. Epub 2010 Nov 11.

DOI:10.1093/cvr/cvq357
PMID:21075756
Abstract

Structural remodelling occurring before, due to the underlying heart disease, and during atrial fibrillation (AF) sets the stage for permanent AF. Current therapy in AF aims to maintain sinus rhythm in symptomatic patients, but outcome is unfortunately poor. Stretch of the atria is a main contributor to atrial remodelling. In this review, we describe different aspects of structural remodelling as seen in animal models and in patients with AF, including atrial enlargement, cellular hypertrophy, dedifferentiation, fibrosis, apoptosis, and loss of contractile elements. In the second part, we describe downstream signals of mechanical stretch and their contribution to AF and structural remodelling. Ultimately, knowledge of mechanisms underlying structural remodelling may help to identify new pharmacological targets for AF prevention.

摘要

结构重构发生在心房颤动 (AF) 之前、期间和由于潜在的心脏病,为永久性 AF 奠定了基础。目前 AF 的治疗旨在维持有症状患者的窦性节律,但结果并不理想。心房的拉伸是心房重构的主要原因之一。在这篇综述中,我们描述了在动物模型和 AF 患者中观察到的结构重构的不同方面,包括心房扩张、细胞肥大、去分化、纤维化、细胞凋亡和收缩元件丢失。在第二部分,我们描述了机械拉伸的下游信号及其对 AF 和结构重构的贡献。最终,对结构重构潜在机制的认识可能有助于确定 AF 预防的新的药理学靶点。

相似文献

1
Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.在心房颤动早期发生之前和期间,拉伸引起的心房结构变化的机制。
Cardiovasc Res. 2011 Mar 1;89(4):754-65. doi: 10.1093/cvr/cvq357. Epub 2010 Nov 11.
2
[Remodelling in atrial fibrillation].[心房颤动中的重塑]
Arch Mal Coeur Vaiss. 2005 Apr;98(4):308-12.
3
Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.心房纤维化:心房颤动的机制及临床意义
J Am Coll Cardiol. 2008 Feb 26;51(8):802-9. doi: 10.1016/j.jacc.2007.09.064.
4
Atrial structural remodeling as an antiarrhythmic target.心房结构重塑作为抗心律失常靶点。
J Cardiovasc Pharmacol. 2008 Jul;52(1):4-10. doi: 10.1097/FJC.0b013e3181668057.
5
Atrial fibrillation and atrial fibrosis.心房颤动与心房纤维化。
J Cardiovasc Pharmacol. 2011 Jun;57(6):625-9. doi: 10.1097/FJC.0b013e3182073c78.
6
[Morphological remodeling in atrial fibrillation].[心房颤动中的形态重塑]
Herz. 2006 Apr;31(2):101-7; quiz 142-3. doi: 10.1007/s00059-006-2788-8.
7
Novel upstream approaches to prevent atrial fibrillation perpetuation.预防心房颤动持续存在的新型上游方法。
Cardiol Clin. 2014 Nov;32(4):637-50. doi: 10.1016/j.ccl.2014.07.004. Epub 2014 Aug 22.
8
Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.追溯术后心房颤动的起源:氧化应激介导的心肌损伤现象的概念。
Eur J Cardiovasc Prev Rehabil. 2008 Dec;15(6):735-41. doi: 10.1097/HJR.0b013e328317f38a.
9
Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.不同类型二尖瓣病变所致心房颤动的心房结构重构不同。
Europace. 2010 Mar;12(3):371-7. doi: 10.1093/europace/eup438. Epub 2010 Jan 26.
10
Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.射频改良迷宫手术后窦性心律维持及房颤复发的预测因素
Eur J Cardiothorac Surg. 2008 Oct;34(4):771-5. doi: 10.1016/j.ejcts.2008.07.026. Epub 2008 Sep 2.

引用本文的文献

1
Hybrid Ablation in Atrial Fibrillation: Bridging Mechanistic Understanding and Clinical Practice.心房颤动的杂交消融:弥合机制理解与临床实践之间的差距
J Cardiovasc Dev Dis. 2025 Aug 19;12(8):313. doi: 10.3390/jcdd12080313.
2
Sleep Disruption and Atrial Fibrillation: Evidence, Mechanisms and Clinical Implications.睡眠中断与心房颤动:证据、机制及临床意义
Circ Res. 2025 Aug 15;137(5):788-808. doi: 10.1161/CIRCRESAHA.125.325612. Epub 2025 Aug 14.
3
The left atrium in heart failure with preserved ejection fraction: What we know and what we do not know.
射血分数保留的心力衰竭中的左心房:我们所知道的和我们不知道的。
Heart Rhythm O2. 2025 Apr 24;6(7):1028-1038. doi: 10.1016/j.hroo.2025.04.007. eCollection 2025 Jul.
4
Histone Deacetylase 6 Controls Atrial Fibrosis and Remodeling in Postinfarction Mice Through the Modulation of Wnt3a/GSK-3β Signaling.组蛋白去乙酰化酶6通过调节Wnt3a/GSK-3β信号通路控制心肌梗死后小鼠的心房纤维化和重构。
FASEB J. 2025 May 31;39(10):e70650. doi: 10.1096/fj.202500371R.
5
Clinical applications of artificial intelligence and machine learning in neurocardiology: a comprehensive review.人工智能与机器学习在神经心脏病学中的临床应用:综述
Front Cardiovasc Med. 2025 Apr 3;12:1525966. doi: 10.3389/fcvm.2025.1525966. eCollection 2025.
6
Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation-Data From the RACE V Study.多重疾病与阵发性心房颤动患者的症状严重程度和疾病进展相关——来自RACE V研究的数据。
J Am Heart Assoc. 2025 Mar 4;14(5):e034514. doi: 10.1161/JAHA.123.034514. Epub 2025 Feb 26.
7
Association of central arterial stiffness with atrial myopathy: the Atherosclerosis Risk in Communities (ARIC) study.中心动脉僵硬与心房肌病的关系:动脉粥样硬化风险社区(ARIC)研究。
Hypertens Res. 2024 Oct;47(10):2902-2913. doi: 10.1038/s41440-024-01831-3. Epub 2024 Aug 8.
8
Cardiac power output is associated with adverse outcomes in patients with preserved ejection fraction after transcatheter aortic valve implantation.在经导管主动脉瓣植入术后射血分数保留的患者中,心脏输出功率与不良预后相关。
Eur Heart J Imaging Methods Pract. 2024 May 21;2(2):qyae048. doi: 10.1093/ehjimp/qyae048. eCollection 2024 Apr.
9
Mechanisms of stretch-induced electro-anatomical remodeling and atrial arrhythmogenesis.牵张诱导的电解剖重构和心房心律失常发生的机制。
J Mol Cell Cardiol. 2024 Aug;193:11-24. doi: 10.1016/j.yjmcc.2024.05.011. Epub 2024 May 24.
10
Synergistic Effects of Weight Loss and Catheter Ablation: Can microRNAs Serve as Predictive Biomarkers for the Prevention of Atrial Fibrillation Recurrence?减肥与导管消融联合治疗的协同效应:微小 RNA 能否作为预防心房颤动复发的预测性生物标志物?
Int J Mol Sci. 2024 Apr 25;25(9):4689. doi: 10.3390/ijms25094689.